Kentucky’s annual rate of opioid-related fatalities remains one of the highest nationwide. Their addiction treatment system is struggling with the limited resources that are allotted to substance use disorder treatment, which is 10.7% of Kentucky’s annual budget. According to an article by the NKY Tribune posted in January of 2020, a new Kentucky Health Issues Poll (KHIP) report shows an uptick in prescription pain medicine misuse last year (2019), while heroin and methamphetamine use remained a steady problem. Nearly two in five Kentucky adults in 2019 said they knew someone who misused prescription pain meds, compared to about one in five for meth and heroin, according to the KHIP report. The state of Kentucky appears to fall near the lower half of the ranking of COVID-19 cases per state, but that does not mean they have not been impacted severely. Fatal overdoses in Lexington have increased at least 42 percent compared to this time last year. The Lexington Herald Leader says that Health and law enforcement officials across more than ten Kentucky counties have reported similar trajectories in their communities – an increase of overdoses, which remained steady over the past two months then periodically surging. Prioritizing wrap around services (see bio-psycho-social model) and person-focused care during this time for Kentuckians is essential for getting people back in the workforce and achieving lifelong recovery after COVID 19. Gone are the days of simply sending people straight into outpatient or inpatient treatment without an end goal in sight. A life with meaning and free from dangerous substances should be the new standard of quality care. Kentuckians, especially those in the hardest hit areas of Lexington and Louisville, are lacking evidence-based treatment options. BrightView is offering Kentuckians a different kind of approach to addiction treatment. Instead of methadone, we offer several other medications, medically proven to help those with dependence on opioid drugs. These medications are considered maintenance medications, commonly used to treat conditions which are chronic or long-term. BrightView treats addiction with FDA-approved medicines (like buprenorphine) to help you focus on your recovery. We also prescribe medicines such as naltrexone (Vivitrol), a combination of buprenorphine and naloxone (suboxone). In almost all BrightView’s Ohio centers, there is an on-site pharmacy, so essentially, a “one stop” shop for patients is available. Although the procedure to be approved for an on-site pharmacy is often elaborate and complicated, BrightView has already taken the needed steps to advocate for on-site pharmacies for our newest locations in Lexington and Louisville. In the meantime, in Kentucky, BrightView will work closely with local businesses, to ensure that each patient has a designated pharmacy to place, fill, and pick up a prescription. Our goal at BrightView is to provide drug abuse treatment options that will help someone achieve long-term recovery. In addition to addiction medicine, a person’s treatment plan will focus on their overall mental health. BrightView incorporates both individual and group therapy in our treatment services so that patients can address the challenges that come along with the disease of addiction. If you or someone you love is struggling with substance abuse, we encourage you to contact us today. Our friendly and caring recovery center staff answer the phones 24 hours a day:. 1-833-510-HELP (4357).
July 17, 2020